These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 37743017)

  • 41. Cardiac troponins: are there any differences between T and I?
    Perrone MA; Storti S; Salvadori S; Pecori A; Bernardini S; Romeo F; Guccione P; Clerico A
    J Cardiovasc Med (Hagerstown); 2021 Nov; 22(11):797-805. PubMed ID: 33399346
    [TBL] [Abstract][Full Text] [Related]  

  • 42. High-Sensitivity Cardiac Troponin I Is a Strong Predictor of Cardiovascular Events and Mortality in the AGES-Reykjavik Community-Based Cohort of Older Individuals.
    Thorsteinsdottir I; Aspelund T; Gudmundsson E; Eiriksdottir G; Harris TB; Launer LJ; Gudnason V; Venge P
    Clin Chem; 2016 Apr; 62(4):623-30. PubMed ID: 26936931
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cardiac troponin I and T for ruling out coronary artery disease in suspected chronic coronary syndrome.
    Tveit SH; Myhre PL; Hanssen TA; Forsdahl SH; Iqbal A; Omland T; Schirmer H
    Sci Rep; 2022 Jan; 12(1):945. PubMed ID: 35042885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls.
    Aakre KM; Røraas T; Petersen PH; Svarstad E; Sellevoll H; Skadberg Ø; Sæle K; Sandberg S
    Clin Chem; 2014 Jun; 60(6):838-47. PubMed ID: 24619542
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of macrotroponin on the utility of cardiac troponin I as a prognostic biomarker for long term total and cardiovascular disease mortality.
    Lam L; Ha L; Gladding P; Tse R; Kyle C
    Pathology; 2021 Dec; 53(7):860-866. PubMed ID: 34272050
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gender-specific reference values for high-sensitivity cardiac troponin T and I in well-phenotyped healthy individuals and validity of high-sensitivity assay designation.
    Giannitsis E; Mueller-Hennessen M; Zeller T; Schuebler A; Aurich M; Biener M; Vafaie M; Stoyanov KM; Ochs M; Riffel J; Mereles D; Blankenberg S; Katus HA
    Clin Biochem; 2020 Apr; 78():18-24. PubMed ID: 31786204
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac Troponins: Contemporary Biological Data and New Methods of Determination.
    Chaulin A
    Vasc Health Risk Manag; 2021; 17():299-316. PubMed ID: 34113117
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Skeletal Muscle Disorders: A Noncardiac Source of Cardiac Troponin T.
    du Fay de Lavallaz J; Prepoudis A; Wendebourg MJ; Kesenheimer E; Kyburz D; Daikeler T; Haaf P; Wanschitz J; Löscher WN; Schreiner B; Katan M; Jung HH; Maurer B; Hammerer-Lercher A; Mayr A; Gualandro DM; Acket A; Puelacher C; Boeddinghaus J; Nestelberger T; Lopez-Ayala P; Glarner N; Shrestha S; Manka R; Gawinecka J; Piscuoglio S; Gallon J; Wiedemann S; Sinnreich M; Mueller C;
    Circulation; 2022 Jun; 145(24):1764-1779. PubMed ID: 35389756
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential associations of cardiac troponin T and cardiac troponin I with coronary artery pathology and dynamics in response to short-duration exercise.
    Tveit SH; Cwikiel J; Myhre PL; Omland T; Berge E; Seljeflot I; Flaa A
    Clin Biochem; 2021 Feb; 88():23-29. PubMed ID: 33245871
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic Value of High-Sensitivity Cardiac Troponin T Compared with Risk Scores in Stable Cardiovascular Disease.
    Biener M; Giannitsis E; Kuhner M; Zelniker T; Mueller-Hennessen M; Vafaie M; Trenk D; Neumann FJ; Hochholzer W; Katus HA
    Am J Med; 2017 May; 130(5):572-582. PubMed ID: 28011313
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations.
    Wu Z; Pilbrow AP; Liew OW; Chong JPC; Sluyter J; Lewis LK; Lasse M; Frampton CM; Jackson R; Poppe K; Camargo CA; Cameron VA; Scragg R; Richards AM
    EBioMedicine; 2022 Aug; 82():104170. PubMed ID: 35850010
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of chronic myocardial injury diagnosed by three different cardiac troponin assays in patients admitted with suspected acute coronary syndrome.
    Steiro OT; Langørgen J; Tjora HL; Bjørneklett RO; Skadberg Ø; Bonarjee VVS; Mjelva ØR; Steinsvik T; Lindahl B; Omland T; Aakre KM; Vikenes K
    Clin Chem Lab Med; 2024 Mar; 62(4):729-739. PubMed ID: 37937808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Elevated high-sensitivity cardiac troponin T serum concentration in subjects with spinal cord injury.
    Wagner B; Weidner N; Hug A
    Int J Cardiol; 2023 Nov; 391():131284. PubMed ID: 37619878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Short- and long-term risk stratification using a next-generation, high-sensitivity research cardiac troponin I (hs-cTnI) assay in an emergency department chest pain population.
    Kavsak PA; Wang X; Ko DT; MacRae AR; Jaffe AS
    Clin Chem; 2009 Oct; 55(10):1809-15. PubMed ID: 19679630
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic Value of Serial Changes in High-Sensitivity Cardiac Troponin I and T over 3 Months Using Reference Change Values in Hemodialysis Patients.
    Sandoval Y; Herzog CA; Love SA; Cao J; Hu Y; Wu AH; Gilbertson D; Brunelli SM; Young A; Ler R; Apple FS
    Clin Chem; 2016 Apr; 62(4):631-8. PubMed ID: 26847217
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of high-sensitivity cardiac troponin T with mortality and cardiovascular events in a community-based prospective study in Beijing.
    Xiao W; Cao R; Liu Y; Wang F; Bai Y; Wu H; Ye P
    BMJ Open; 2017 Jun; 7(6):e013431. PubMed ID: 28652289
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of high-sensitivity cardiac troponin I and T for the prediction of cardiac complications after non-cardiac surgery.
    Gualandro DM; Puelacher C; LuratiBuse G; Lampart A; Strunz C; Cardozo FA; Yu PC; Jaffe AS; Barac S; Bock L; Badertscher P; du Fay de Lavallaz J; Marbot S; Sazgary L; Bolliger D; Rentsch K; Twerenbold R; Hammerer-Lercher A; Melo ES; Calderaro D; Duarte AJ; de Luccia N; Caramelli B; Mueller C;
    Am Heart J; 2018 Sep; 203():67-73. PubMed ID: 30041065
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical use of cardiac troponin for acute cardiac care and emerging opportunities in the outpatient setting.
    Sandoval Y; Sharain K; Saenger AK; Smith SW; Apple FS; Jaffe AS
    Minerva Med; 2019 Apr; 110(2):139-156. PubMed ID: 30484592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. High-Sensitivity vs Conventional Troponin Cutoffs for Risk Stratification in Patients With Acute Pulmonary Embolism.
    Bikdeli B; Muriel A; Rodríguez C; González S; Briceño W; Mehdipoor G; Piazza G; Ballaz A; Lippi G; Yusen RD; Otero R; Jiménez D
    JAMA Cardiol; 2024 Jan; 9(1):64-70. PubMed ID: 37991780
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Direct comparison of clinical decision limits for cardiac troponin T and I.
    Kimenai DM; Henry RM; van der Kallen CJ; Dagnelie PC; Schram MT; Stehouwer CD; van Suijlen JD; Niens M; Bekers O; Sep SJ; Schaper NC; van Dieijen-Visser MP; Meex SJ
    Heart; 2016 Apr; 102(8):610-6. PubMed ID: 26794233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.